HomePLRX • NASDAQ
Pliant Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 28.37M | -54.25% |
Net income | -26.30M | 54.47% |
Net profit margin | — | — |
Earnings per share | -0.43 | 54.74% |
EBITDA | -27.93M | 54.57% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 241.80M | -40.23% |
Total assets | 276.60M | -37.94% |
Total liabilities | 76.29M | -23.59% |
Total equity | 200.31M | — |
Shares outstanding | 61.45M | — |
Price to book | 0.48 | — |
Return on assets | -24.61% | — |
Return on capital | -26.24% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -26.30M | 54.47% |
Cash from operations | -21.08M | 34.68% |
Cash from investing | 27.92M | -9.82% |
Cash from financing | 72.00K | -86.74% |
Net change in cash | 6.91M | 997.66% |
Free cash flow | -13.54M | 18.17% |
Previous close
$1.57
Day range
$1.48 - $1.63
Year range
$1.10 - $15.80
Market cap
92.17M USD
Avg Volume
954.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
171
